- Programs & Services
- Cost Management
- Specialty Management
- Care Management
- Member Engagement
- Health Plan Client Engagement
Alzheimer’s, oncology and atopic dermatitis therapies in the approvals pipeline
Specialty Pharmacy Pipeline:
Drugs to Watch Report
Anticipated Launches | Q2 – Q3 2021
The Specialty Pharmacy Pipeline Drugs to Watch report for Q2 2021 to Q3 2021 highlights two drugs for the treatment of atopic dermatitis and several other medications with near-term approvals for conditions such as Alzheimer’s disease, oncology and psoriasis.
The report details anticipated impact on spend for these therapies, including potential shifts between pharmacy and medical, as well as planned updates to CVS Health’s Specialty Guideline Management.